# Antisynthetase Syndrome Mimicking Pulmonary Infection: A Diagnostic Lesson From County‐Managed Hospital

**Authors:** Jufen Cheng

PMC · DOI: 10.1002/ccr3.72085 · Clinical Case Reports · 2026-02-24

## TL;DR

A 75-year-old man with symptoms resembling a lung infection was later diagnosed with antisynthetase syndrome, highlighting the need for early antibody testing and bronchoscopy in atypical cases.

## Contribution

This case highlights the atypical presentation of antisynthetase syndrome in elderly males and emphasizes the importance of early diagnostic testing.

## Key findings

- Antisynthetase syndrome can mimic pulmonary infection in elderly males.
- Delayed diagnosis occurred due to initial misinterpretation of symptoms.
- Corticosteroid treatment led to significant clinical improvement.

## Abstract

Antisynthetase syndrome (ASS) is a rare chronic autoimmune disease classified as a distinct subtype of idiopathic inflammatory myopathy, characterized by the presence of anti–aminoacyl‐transfer RNA synthetase (anti‐ARS) antibodies. Typical clinical features include myositis, interstitial lung disease (ILD), arthritis, fever, mechanic's hands, and Raynaud's phenomenon, with a predominance in middle‐aged to elderly females. We report an atypical case of a 75‐year‐old male presenting with a 6‐month history of anorexia and fatigue, followed by a 3‐week progression of chest tightness and dyspnea. Initially misdiagnosed as a pulmonary infection, the patient showed no improvement after two weeks of antimicrobial therapy. Diagnosis was ultimately confirmed through bronchoscopy and detection of anti–Jo‐1 antibodies. Subsequent corticosteroid treatment led to complete radiographic resolution and significant clinical improvement. This case underscores the importance of considering ASS in elderly male patients to prevent misdiagnosis and ensure timely intervention.

Antisynthetase syndrome can atypically present in elderly males with respiratory symptoms mimicking pulmonary infection. When antibiotic therapy fails, early serologic testing for anti‐synthetase antibodies (e.g., anti‐EJ) and bronchoscopy are essential. Prompt immunosuppressive treatment significantly improves outcomes in such cases.

## Linked entities

- **Diseases:** antisynthetase syndrome (MONDO:0019344), interstitial lung disease (MONDO:0015925), arthritis (MONDO:0005578)

## Full-text entities

- **Genes:** IFIH1 (interferon induced with helicase C domain 1) [NCBI Gene 64135] {aka AGS7, Hlcd, IDDM19, IMD95, MDA-5, MDA5}, RIEG2 (Rieger syndrome 2) [NCBI Gene 6012] {aka ARS, RGS2}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** MCTD (MESH:D008947), dermatomyositis (MESH:D003882), digital vasospasm (MESH:D020301), digital ischemia (MESH:D007511), Fever (MESH:D005334), respiratory distress (MESH:D012128), vascular complications (MESH:D003925), IIMs (MESH:D009220), chest pain (MESH:D002637), fatigue (MESH:D005221), hemoptysis (MESH:D006469), pneumonia (MESH:D011014), Pleural effusion (MESH:D010996), rash (MESH:D005076), respiratory difficulty (MESH:D012131), pulmonary infiltrates (MESH:D017254), cutaneous lesions (MESH:D009059), autoimmune (MESH:D001327), edema (MESH:D004487), anorexia (MESH:D000855), dyspnea (MESH:D004417), malignancy (MESH:D009369), cyanosis (MESH:D003490), muscle weakness (MESH:D018908), lung lesions (MESH:D008171), diabetes mellitus (MESH:D003920), occlusive vascular disease (MESH:D008641), inflammation (MESH:D007249), Pulmonary Infection (MESH:D012141), trauma (MESH:D014947), pulmonary involvement (MESH:C566343), syncope (MESH:D013575), lethargic (MESH:D004674), infectious (MESH:D003141), erythema (MESH:D004890), muscular (MESH:D009135), ASS-ILD (MESH:D017563), hepatitis (MESH:D056486), tuberculosis (MESH:D014376), allergies (MESH:D004342), tenderness (MESH:D063806), pulmonary fibrosis (MESH:D011658), Raynaud's phenomenon (MESH:D011928), deformities (MESH:D009140), organizing pneumonia (MESH:D000092124), joints (MESH:D007592), arthralgia (MESH:D018771), cough (MESH:D003371), chest discomfort (MESH:D013898), dizziness (MESH:D004244), leukocytosis (MESH:D007964), cardiovascular or cerebrovascular diseases (MESH:D002318), infection (MESH:D007239), ASS (MESH:C537778), effusions (MESH:D000080324), respiratory and pulmonary syndromes (MESH:D012120), chills (MESH:D023341), hypertension (MESH:D006973), arthritis (MESH:D001168)
- **Chemicals:** moxifloxacin (MESH:D000077266), methylprednisolone (MESH:D008775), tocilizumab (MESH:C502936), oxygen (MESH:D010100), glucose (MESH:D005947), steroid (MESH:D013256), prednisone (MESH:D011241), rituximab (MESH:D000069283), piperacillin-tazobactam (MESH:D000077725), cefoperazone-sulbactam (-)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Chlamydia pneumoniae (species) [taxon 83558], Mycoplasmoides pneumoniae (Filterable agent of primary atypical pneumonia, species) [taxon 2104], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** P115 A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932121/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932121/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932121/full.md

---
Source: https://tomesphere.com/paper/PMC12932121